(1-ethyl-8-fluorospiro[chromeno[3,4-d]pyrazole-4,4'-piperidine]-1'-yl)-(2-methoxyphenyl)methanone;(7'-fluorospiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-yl)-[4-(2-methoxyethoxy)-3-methylphenyl]methanone;N-methyl-4-[1'-(trifluoromethyl)spiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-carbonyl]benzenesulfonamide;molecular hydrogen
C74H75F5N8O11S — CID 158526617
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1-ethyl-8-fluorospiro[chromeno[3,4-d]pyrazole-4,4'-piperidine]-1'-yl)-(2-methoxyphenyl)methanone;(7'-fluorospiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-yl)-[4-(2-methoxyethoxy)-3-methylphenyl]methanone;N-methyl-4-[1'-(trifluoromethyl)spiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-carbonyl]benzenesulfonamide;molecular hydrogen
(1-ethyl-8-fluorospiro[chromeno[3,4-d]pyrazole-4,4'-piperidine]-1'-yl)-(2-methoxyphenyl)methanone;(7'-fluorospiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-yl)-[4-(2-methoxyethoxy)-3-methylphenyl]methanone;N-methyl-4-[1'-(trifluoromethyl)spiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-carbonyl]benzenesulfonamide;molecular hydrogen (PubChem CID 158526617) has the molecular formula C74H75F5N8O11S and a molecular weight of 1379.52 g/mol. Its IUPAC name is (1-ethyl-8-fluorospiro[chromeno[3,4-d]pyrazole-4,4'-piperidine]-1'-yl)-(2-methoxyphenyl)methanone;(7'-fluorospiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-yl)-[4-(2-methoxyethoxy)-3-methylphenyl]methanone;N-methyl-4-[1'-(trifluoromethyl)spiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-carbonyl]benzenesulfonamide;molecular hydrogen.
Molecular Properties
| Compound Name | (1-ethyl-8-fluorospiro[chromeno[3,4-d]pyrazole-4,4'-piperidine]-1'-yl)-(2-methoxyphenyl)methanone;(7'-fluorospiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-yl)-[4-(2-methoxyethoxy)-3-methylphenyl]methanone;N-methyl-4-[1'-(trifluoromethyl)spiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-carbonyl]benzenesulfonamide;molecular hydrogen |
|---|---|
| PubChem CID | 158526617 |
| Molecular Formula | C74H75F5N8O11S |
| Molecular Weight | 1379.52 g/mol |
| Exact Mass | 1378.52 |
| IUPAC Name | (1-ethyl-8-fluorospiro[chromeno[3,4-d]pyrazole-4,4'-piperidine]-1'-yl)-(2-methoxyphenyl)methanone;(7'-fluorospiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-yl)-[4-(2-methoxyethoxy)-3-methylphenyl]methanone;N-methyl-4-[1'-(trifluoromethyl)spiro[piperidine-4,4'-pyrrolo[2,1-c][1,4]benzoxazine]-1-carbonyl]benzenesulfonamide;molecular hydrogen |
| SMILES | CCn1ncc2c1-c1cc(F)ccc1OC21CCN(C(=O)c2ccccc2OC)CC1.CNS(=O)(=O)c1ccc(C(=O)N2CCC3(CC2)Oc2ccccc2-n2c(C(F)(F)F)ccc23)cc1.COCCOc1ccc(C(=O)N2CCC3(CC2)Oc2cc(F)ccc2-n2cccc23)cc1C.[H][H] |
| InChI | InChI=1S/C26H27FN2O4.C24H22F3N3O4S.C24H24FN3O3.H2/c1-18-16-19(5-8-22(18)32-15-14-31-2)25(30)28-12-9-26(10-13-28)24-4-3-11-29(24)21-7-6-20(27)17-23(21)33-26;1-28-35(32,33)17-8-6-16(7-9-17)22(31)29-14-12-23(13-15-29)20-10-11-21(24(25,26)27)30(20)18-4-2-3-5-19(18)34-23;1-3-28-22-18-14-16(25)8-9-21(18)31-24(19(22)15-26-28)10-12-27(13-11-24)23(29)17-6-4-5-7-20(17)30-2;/h3-8,11,16-17H,9-10,12-15H2,1-2H3;2-11,28H,12-15H2,1H3;4-9,14-15H,3,10-13H2,1-2H3;1H |
| InChIKey | HMWAFMSLSHKQLD-UHFFFAOYSA-N |
| XLogP | 12.89 |
| TPSA | 190.16 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 99 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1379.52 |
| LogP ≤ 5 | 12.89 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'pyrrole_A(118)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158526617 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.